BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12136249)

  • 1. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
    Fu XS; Choi E; Bubley GJ; Balk SP
    Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer.
    Vleugel MM; Greijer AE; van der Wall E; van Diest PJ
    Cancer Genet Cytogenet; 2005 Dec; 163(2):168-72. PubMed ID: 16337862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.
    Srinivas V; Zhang LP; Zhu XH; Caro J
    Biochem Biophys Res Commun; 1999 Jul; 260(2):557-61. PubMed ID: 10403805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
    Zhong H; Agani F; Baccala AA; Laughner E; Rioseco-Camacho N; Isaacs WB; Simons JW; Semenza GL
    Cancer Res; 1998 Dec; 58(23):5280-4. PubMed ID: 9850048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
    Monsef N; Helczynski L; Lundwall A; PĂ„hlman S;
    Prostate; 2007 Aug; 67(11):1219-29. PubMed ID: 17562539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells.
    Coffey RN; Morrissey C; Taylor CT; Fitzpatrick JM; Watson RW
    Cancer; 2005 Apr; 103(7):1363-74. PubMed ID: 15719438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.
    Ghafar MA; Anastasiadis AG; Chen MW; Burchardt M; Olsson LE; Xie H; Benson MC; Buttyan R
    Prostate; 2003 Jan; 54(1):58-67. PubMed ID: 12481256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X
    Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
    Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
    Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
    Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
    Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.
    Jung SN; Yang WK; Kim J; Kim HS; Kim EJ; Yun H; Park H; Kim SS; Choe W; Kang I; Ha J
    Carcinogenesis; 2008 Apr; 29(4):713-21. PubMed ID: 18258605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
    Cohen NA; Lai SY; Ziober AF; Ziober BL
    Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.